Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Breast Neoplasms 1256Neoplasms 1074Carcinoma, Non-Small-Cell Lung 874Prostatic Neoplasms 714Lung Neoplasms 596Colorectal Neoplasms 590Neoplasm Metastasis 452Multiple Myeloma 432Leukemia, Myeloid, Acute 423Pancreatic Neoplasms 370Ovarian Neoplasms 367Melanoma 324Carcinoma, Hepatocellular 299Squamous Cell Carcinoma of Head and Neck 276Brain Neoplasms 275Recurrence 273Stomach Neoplasms 245Head and Neck Neoplasms 241Glioblastoma 239Carcinoma, Renal Cell 227Lymphoma 226Triple Negative Breast Neoplasms 225Precursor Cell Lymphoblastic Leukemia-Lymphoma 222Hematologic Neoplasms 212Urinary Bladder Neoplasms 211Uterine Cervical Neoplasms 200Endometrial Neoplasms 199Sarcoma 195Glioma 194Lymphoma, Non-Hodgkin 188

Interventions

Injections 4tislelizumab 2Paclitaxel 2Cisplatin 2Capecitabine 2Bevacizumab 2Pemetrexed 1Oxaliplatin 1Gemcitabine 1Fluorouracil 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advanced Solid Tumour × 90 days × Clear all
NCT07111546 2026-05-26

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
140 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT06783647 2026-05-18

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
230 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT07331155 2026-05-18

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT07390383 2026-05-13

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡